• Towards a sustainable Ontario Drug Benefit Program
• OPA submission on OCP expanded scope of practice consultation

• Identifying Drug Interactions
• Pharmacist Health Coaching – Cardiovascular Program Training Course
• Interprofessional Relationships and Conflict Management in Primary Care

• Ask the Practice Support Network
• Flash Sale: Save 30% Off Dell XPS and Alienware

• Universal Influenza Immunization Program and Store Insurance
• Last chance to win a tablet

• DDD Notice No. 19160 posted October 29, 2019 Prescription Forgery Alert
• DDD Notice No. 19159 Posted October 29, 2019 Health Network System (HNS) And Narcotics Monitoring System (NMS) Outage Notification to Ontario Drug Programs Agencies
• DDD Notice No. 19158 posted October 29, 2019 Prescription Forgery Alert
• DDD Notice No. 19157 posted October 28, 2019 Notice: Proposal to Reduce Administrative Burden to Drug Manufacturers and Pharmacies
• DDD Notice No. 19156 posted October 28, 2019 Notice: Proposal to Improve the Value of Pharmacy Payments
• DDD Notice No. 19155 posted October 24, 2019 ODB Formulary – Edition No. 43, Summary of Changes – October 2019
• DDD Notice No. 19154 posted October 23, 2019 Prescription Forgery Alert

• Drug Shortage / Supply Health System Alert: Tamoxifen

• ICYMI: 2019-20 Universal Influenza Immunization Program (UIIP) Updates
• Last week to submit feedback on proposed amendments to expand the scope of practice for pharmacists
• OPA's Student Advisory Council gets underway
• McMaster University survey on cannabis

• FREE - Assessment and Management of Patients with Migraine
• FREE - Introduction to Caring for Trans Patients in the Pharmacy
• Selling What You Can Do for Your Clients Program

• Ask the Customer Experience and Administration Team
• Spooky Halloween party at Ripley's Aquarium of Canada

• Store Insurance Risk Prevention
• Last chance to win a tablet

• DDD Notice No. 19152 posted October 17, 2019 Prescription Forgery Alert
• DDD Notice No. 19151 posted October 16, 2019 Notice: Pharmacist administration of publicly funded influenza vaccines and claims submission using the Health Network System

• Additional ranitidine products recalled, including Zantac; request to stop distribution remains in place while Health Canada continues to assess NDMA

• Today was Pharmacy Technician Day!
• OPP reminder regarding prescription forgeries
• OPA Student Chapter Executive Teams announced
• U of T Pharmacy Undergraduate Awards
• U of T 8T9 Class Reunion

• Personal Branding for Pharmacy Professionals
• FREE! An Introduction to Caring for Trans Patients in the Pharmacy
• An Update on Direct Oral Anticoagulation

• Ask the Practice Support Network

• Must-have insurance
• Win a tablet with the best-in-class coverage

• Drug Shortage / Supply Health System Alert: SOGC Statement - Oxytocin

• Some EpiPen and EpiPen Jr auto-injectors may be difficult to remove from their carrier tubes
• Avalon Fetal Monitor - Risk of Inaccurate Ultrasound-Derived Fetal Heart Rate Monitoring
• LEMTRADA® (alemtuzumab) – Risk of Autoimmune Hepatitis, Haemophagocytic Lymphohistiocytosis, and Associated Serious Cardiovascular Reactions - sanofi-aventis Canada Inc.

• Reminder to complete our survey on the first three initiatives to expand scope of practices for pharmacists
• Federal campaign resources from our pharmacy partners

• Paid Consultations - Opportunities and Timesavers
• Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
• Injections and Immunizations Program

• Ask the Customer Experience and Administration Team

• Surviving a critical illness
• Win a tablet with the best-in-class coverage

• Drug Shortage / Supply Health System Alert: Multiple Oncology Products (Fludarabine, Hydroxyurea, Raltitrexed, Tamoxifen)
• Drug Shortage / Supply Health System Alert: Pfizer Canada - Oxytocin 1ml ampoule

• DDD Notice No. 19147 posted October 4, 2019 Prescription Forgery Alert
• DDD Notice No. 19148 posted October 4, 2019 Prescription Forgery Alert

• Complete our survey on the first three initiatives to expand scope of practices for pharmacists

• Opioid Addictions and Substitution Therapy FREE Online Modules
• The Master Plan for Diabetes Continuing Education Program
• Identifying Drug Interactions

• Ask the Practice Support Network

• OPA Secure Health Plan: All-in-one health care package
• Win a tablet with the best-in-class coverage

• Drug Shortage / Supply Health System Alert: Fresenius Kabi - Oxytocin 1ml vial

• DDD Notice No. 19141 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19140 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19139 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19138 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19137 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19136 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19135 posted September 30, 2019 Prescription Forgery Alert
• DDD Notice No. 19134 posted September 30, 2019 Notice from the Executive Office

• Ranitidine - Information Update
• Health Product InfoWatch - September 2019

• Fluzone® High-Dose not made available in pharmacy this flu season
• September 25, 2019 is World Pharmacists Day!

• Take-Home Naloxone Program at Community Pharmacies
• Opioid Addiction and Substitution Therapy Free Live Webinar Series
• Medical Devices Training for Pharmacy Technicians

• Ask the Customer Experience and Administration Team
• Don't miss out! TELUS bonus offer ends September 30, 2019

• Protect your vehicle and home with the right insurance coverage

• DDD Notice No. 19133 posted September 20, 2019 ODB Formulary – Edition No. 43, Summary of Changes – September 2019 Summary of Product Changes

• Gripe Water - Information Update
• Abbott brand Calcilo XD Powder recalled due to rancidity and off-colour

• September 17, 2019 is declared the first World Patient Safety Day
• Your fall issue of Ontario Pharmacist and Ontario Pharmacy Technician magazines are here!

• Injections and Immunizations Program
• How-To: Ontario's Pharmaceutical Opinion Program
• Identifying Drug Interactions

• Ask the Practice Support Network
• A new focus on students: an engagement strategy
• Take the 2019-20 OPA membership survey

• Professional liability coverage - practising in another province

• Pfizer Canada supply update on PrZINECARD®

• DDD Notice No. 19130 posted September 13, 2019 Notice from the Executive Officer
• DDD Notice No. 19127 posted September 12, 2019 Notice from the Executive Officer: Funding Flash Glucose Monitoring System Through the Ontario Drug Benefit Program

• Gabapentin or Pregabalin with Opioids - Information Update
• Health Canada requests that companies stop distributing ranitidine drugs in Canada while it assesses NDMA; some products being recalled
• Needle-free dermal filler devices - Information Update

• FluMist Quadrivalent not available this year
• International Federation on Ageing unites groups to improve vaccination rates
• Innovative Medicines Canada announces changes to Code of Ethical Practices
• Political parties gear up for federal election

• FREE! An Introduction to Caring for Trans Patients in the Pharmacy
• Implementing Smoking Cessation Services in the Pharmacy
• Injections and Immunizations Program

• Ask the Customer Experience and Administration Team
• Travel discounts as an associate member of CPhA

• Why buy life insurance?

• Drug Shortage / Supply Health System Alert: multiple cancer drugs

• Notice No. 19125 posted September 10, 2019 Prescription Forgery Alert